Plain-English translation of NCT05974631 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing two different therapy approaches for veterans who have both PTSD and recent suicidal thoughts or behaviors. One approach combines Dialectical Behavior Therapy (DBT)—which focuses on managing suicidal crises and emotions—with a specialized exposure therapy for PTSD. The other approach uses exposure therapy for PTSD with added suicide safety planning. The study will compare which treatment works better and is safer for this high-risk group.
Many effective therapies for PTSD exist, but doctors have historically avoided using them with people at immediate risk for suicide because there wasn't enough research proving they were safe in this situation. This creates a dangerous gap: veterans who need PTSD treatment the most often can't access it. This trial aims to fill that gap by rigorously testing both approaches so doctors will have clear guidance on how to safely treat PTSD in people at elevated suicide risk.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to receive one of the two therapy programs. One group will participate in a full year of DBT combined with specialized exposure therapy for PTSD. The other group will receive up to 18 sessions of exposure therapy with added suicide safety planning. You'll attend regular therapy sessions over about 12–18 months, and the study team will monitor your progress, safety, and symptoms throughout the program.
AI-generated summary from trial data · Aug 11, 2026 · Not medical advice
United States